Skip to content

Screener

Eligibility screening

Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Sponsored by Daiichi SankyoStudy detailsClinicalTrials.gov

6 US sites in CA, MI, TN, TX +1

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.